BioCentury
ARTICLE | Clinical News

Betatropin: Phase II

September 17, 2001 7:00 AM UTC

Restoragen said subcutaneous infusion of Betatropin improved blood glucose levels in Type II diabetics over a 7 day infusion period compared to placebo. Results of the 47 patient, double-blind, dose-r...